Antiangiogenic immunotherapy suppresses desmoplastic and chemoresistant intestinal tumors in mice

Journal: Journal of Clinical Investigation

Published: 2020-03-02

DOI: 10.1172/jci129558

Affiliations: 9

Authors: 20

Go to article
Institutions Share
University Hospital of Lausanne (CHUV), UNIL, Switzerland 0.27
EPFL Swiss Institute for Experimental Cancer Research (ISREC), Switzerland 0.18
LICR Lausanne Branch, Switzerland 0.17
EPFL School of Life Sciences (SV), Switzerland 0.10
Roche Pharma Research and Early Development (Roche pRED), Switzerland 0.10
SIB Bioinformatics Core Facility (BCF), Switzerland 0.09
Institute of Molecular Cancer Research (IMCR), UZH, Switzerland 0.05
Center for Vascular and Developmental Biology, NU, United States of America (USA) 0.05

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER